Professor Sarah Tabrizi (UCL Institute of Neurology) is leading the trial of a new drug that might slow the progression of Huntington's disease. Research by Professor Gill Bates (UCL Institute of Neurology) is also mentioned and Dr Ed Wild and Professor John Hardy (UCL Institute of Neurology) are quoted.
Read: The Independent
Close
